About: pharmaceutical companies

Health 09-07-2020

MEP: A common EU tool to incentivise production and availability of orphan drugs

When it comes to rare diseases and 'orphan drugs', technology is there to support an “objective” EU tool that could provide the pharma industry with the necessary incentives to research and produce orphan drugs and simultaneously avoid exhausting ailing health systems, MEP Stelios Kympouropoulos told EURACTIV in an interview.
Health 08-07-2020

EU orphan drugs law and the emergence of SMEs

The legal framework provided by the current EU orphan drugs regulation has encouraged a number of small and medium sized companies (SMEs) to develop innovative technologies in the fight against rare diseases in Europe, stakeholders told EURACTIV.com.
Health 07-07-2020

EURORDIS: Rare diseases need more centralised processes within the EU

Future improvement of the EU Orphan Medicines Regulation (OMP) could involve more centralised processes for all rare diseases at the EU level, the European Organisation for Rare Diseases  (EURORDIS) told EURACTIV in a written interview.
Future EU 23-06-2020

German EU Presidency: Influenced by lobbyists?

Large lobbying associations have a strong influence on the German government and there are concerns that this might impact its EU Council presidency, which starts on 1 July, warned a study conducted by NGOs LobbyControl and Corporate Europe Observatory. EURACTIV Germany reports.
Health 28-06-2019

New pharma boss: Next EU Commission should be clear on how to protect innovation

The next EU Commission should take a stronger position on innovation in the pharma sector, the new leader of the European Federation of Pharmaceutical Industries and Associations (EFPIA) told EURACTIV.com in an interview.
Health 29-05-2019

AMR incentives could be next big EU opportunity, pharma boss says

Europe could become the first region worldwide to incentivise the fight anti-microbial resistance (AMR), Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), told EURACTIV in an interview.
Health 03-07-2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.  
Health 28-05-2018

Roche CEO: US, China dominate healthcare innovation, EU lags ‘far behind’

The US is leading in healthcare innovation, China is catching up at high speed and Europe is just watching the global developments, Roche CEO Severin Schwan warned on Monday (28 May). EURACTIV.com reports from Dublin.
Health 07-05-2018

Pharma boss: Incentives based on outcomes will optimise EU healthcare

An outcomes-based approach for incentives in the pharmaceutical sector would help optimise the entire healthcare systems, Nathalie Moll told EURACTIV.com in an interview.
Health 30-03-2018

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

The generic industry’s request for an SPC (supplementary protection certificates)  manufacturing waiver, which would allow them to produce in the EU SPC-protected drugs for other markets, does not influence or harm innovators’ rights, Marc–Alexander Mahl told EURACTIV.com in an interview. He...
Development Policy 28-03-2018

Africa takes steps to make medicine more affordable

Faced with the numerous difficulties of access to medicine in Africa, African states want to organise the market to increase local production, which currently accounts for 3% of world output.
Brexit 21-03-2018

‘Vital’ UK remains part of EU clinical trials, say MPs

Continued participation in EU-wide clinical trials and the Horizon 2020 research programme is ‘vital’ to the UK’s life sciences sector, according to a new cross-party report by UK MPs.
Brexit 14-03-2018

NHS faces ‘serious challenges’ from Brexit, warns new report

Brexit poses “serious challenges” to the NHS in the form of longer waiting times, staff shortages and delays in the approval of new medicines, according to a report published on Wednesday (14 March).
Health 16-02-2018

Greek judges call for calm over Novartis scandal

The Greek Union of Judges and Prosecutors called for “calmness and sobriety” on Friday (16 February), following a lawsuit by former Prime Minister Antonis Samaras against Premier Alexis Tsipras and Prosecutor of Corruption Eleni Touloupaki over the Novartis scandal.
Health 06-02-2018

Pharma scandal whips up political storm in Greek opposition ranks

A probe into illegal practices of Swiss drugmaker Novartis in Greece, involving thousands of state officials and doctors, has opened the Pandora’s Box in Greek politics as local media have named ten former bigwigs from opposition parties as being targeted by the investigation.
Health 24-01-2018

Health tech bill to kick off busy policy agenda in 2018

The European Commission will propose a new law on Health Technology Assessments to kick off a busy EU health agenda in 2018.
Health 08-12-2017

Drug pricing debate to take place in heated atmosphere

Following a Greek government request, the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) will discuss on Friday (8 December) a recent dispute between Athens and ROCHE, a Swiss multinational company, over the latter’s decision to withdraw a cancer drug from the market.
Health 13-10-2017

New Commission study fuels generic drugs industry ‘manufacturing dispute’

The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.
Health 11-07-2017

Dutch health minister: EMA relocation is not entertainment, listen to the Commission

The European Medicines Agency (EMA) is not a toy to be played with by politicians, Edith Schippers told EURACTIV.com. The decision on the agency's relocation should be based on the European Commission's assessment, she argues in an interview.
Health 05-07-2017

Drug agency relocation talks divide old and new EU members

The debate over where to relocate the London-based European Medicines Agency (EMA) after Brexit has divided the other 27 EU member states, despite calls for an urgent decision from the drugs industry and patient groups.
Brexit 26-04-2017

Drugs firms call for phased transition of regulation after Brexit

Pharmaceutical companies called on Thursday (27 April) for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.
Health 24-04-2017

Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said today (24 April).
Health 10-04-2017

London wants to protect free movement of talent after Brexit

Controls on EU immigration played a key role in the Brexit vote. However, the UK government now says that it wants to protect the free movement of researchers and talent, which are crucial for the life sciences sector. EURACTIV.com reports from Lyon.
Health 22-02-2017

Greek pharma boss: Patients are punished when innovation is penalised

Patients are “punished” due to a lack of innovation-driven structural reforms in a crisis-hit public health system, the head of the Greek pharma industry said in an interview with Euractiv Greece.
Contribute